ES557636A0 - Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina - Google Patents

Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina

Info

Publication number
ES557636A0
ES557636A0 ES557636A ES557636A ES557636A0 ES 557636 A0 ES557636 A0 ES 557636A0 ES 557636 A ES557636 A ES 557636A ES 557636 A ES557636 A ES 557636A ES 557636 A0 ES557636 A0 ES 557636A0
Authority
ES
Spain
Prior art keywords
benzoxapine
oxo
derivatives
amino
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557636A
Other languages
English (en)
Other versions
ES8801653A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1984/000119 external-priority patent/WO1985004402A1/ja
Priority claimed from PCT/JP1984/000172 external-priority patent/WO1985004657A1/ja
Priority claimed from US06/599,187 external-priority patent/US4564612A/en
Priority claimed from PCT/JP1984/000363 external-priority patent/WO1986000618A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of ES557636A0 publication Critical patent/ES557636A0/es
Publication of ES8801653A1 publication Critical patent/ES8801653A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D281/00Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02Seven-membered rings
    • C07D281/04Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/10Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES557636A 1984-03-24 1987-07-29 Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina Expired ES8801653A1 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/JP1984/000119 WO1985004402A1 (en) 1984-03-24 1984-03-24 Fused 7-membered ring compounds and process for their preparation
PCT/JP1984/000172 WO1985004657A1 (en) 1984-04-06 1984-04-06 Fused 7-membered ring compounds and process for their preparation
US06/599,187 US4564612A (en) 1983-04-22 1984-04-11 Condensed, seven-membered ring compounds and their use
PCT/JP1984/000363 WO1986000618A1 (en) 1984-07-13 1984-07-13 Condensed 7-membered ring compounds and process for their preparation

Publications (2)

Publication Number Publication Date
ES557636A0 true ES557636A0 (es) 1988-02-16
ES8801653A1 ES8801653A1 (es) 1988-02-16

Family

ID=27466903

Family Applications (2)

Application Number Title Priority Date Filing Date
ES540548A Expired ES8702389A1 (es) 1984-03-24 1985-02-20 Un procedimiento para preparar nuevos compuestos con anillo condensado de siete miembros.
ES557636A Expired ES8801653A1 (es) 1984-03-24 1987-07-29 Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES540548A Expired ES8702389A1 (es) 1984-03-24 1985-02-20 Un procedimiento para preparar nuevos compuestos con anillo condensado de siete miembros.

Country Status (8)

Country Link
EP (1) EP0156455A3 (es)
JP (1) JPH0215060A (es)
ES (2) ES8702389A1 (es)
FI (1) FI82465C (es)
IE (1) IE850148L (es)
IL (1) IL74004A (es)
NO (1) NO160712C (es)
PH (1) PH23261A (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0657707B2 (ja) * 1987-05-25 1994-08-03 吉富製薬株式会社 ピペリジン化合物
EP0359004A1 (en) * 1988-09-05 1990-03-21 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition for the treatment of hypertension
EP0399432B1 (en) * 1989-05-25 1994-06-22 Takeda Chemical Industries, Ltd. Transdermal therapeutic composition
JPH0338583A (ja) * 1989-07-04 1991-02-19 Nippon Soda Co Ltd 1‐(4‐テトラヒドロピラニル)‐1‐ブテン‐3‐オンの製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3562257A (en) * 1967-10-28 1971-02-09 Tanabe Seiyaku Co Benzothiazepine derivatives
EP0068173B1 (en) * 1981-06-05 1984-09-26 Merck & Co. Inc. Perhydro-1,4-thiazepin-5-one and perhydro-1,4-thiazocin-5-one derivatives, process for preparing and pharmceutical composition containing the same
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
GB2143816A (en) * 1983-06-29 1985-02-20 Mitsui Toatsu Chemicals Benzothiazepine derivatives
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
DE3426720A1 (de) * 1984-07-20 1986-01-23 Hoechst Ag, 6230 Frankfurt Benzthiazepinon- und benzthiazocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung

Also Published As

Publication number Publication date
NO160712B (no) 1989-02-13
FI82465C (fi) 1991-03-11
EP0156455A2 (en) 1985-10-02
ES8702389A1 (es) 1987-01-01
IE850148L (en) 1985-09-22
IL74004A (en) 1991-12-15
FI82465B (fi) 1990-11-30
FI851154A0 (fi) 1985-03-22
FI851154L (fi) 1985-09-23
EP0156455A3 (en) 1987-07-22
IL74004A0 (en) 1985-04-30
PH23261A (en) 1989-06-16
ES8801653A1 (es) 1988-02-16
JPH0563468B2 (es) 1993-09-10
NO850045L (no) 1985-09-23
JPH0215060A (ja) 1990-01-18
NO160712C (no) 1989-05-24
ES540548A0 (es) 1987-01-01

Similar Documents

Publication Publication Date Title
ES543732A0 (es) Un procedimiento para preparar derivados de aminoalquilfenaxi.
ES542051A0 (es) Un procedimiento para preparar derivados de benzoilurea
ES545771A0 (es) Un procedimiento para preparar derivados de quiniona.
ES543047A0 (es) Un procedimiento para preparar un derivado de pirimidina
ES553614A0 (es) Un procedimiento para preparar derivados de alanil-prolina.
ES548073A0 (es) Un procedimiento para la preparacion de derivados de tiazol 2,4-disustituidos
ES538518A0 (es) Un procedimiento para preparar derivados de 3-aminopirazolo-(3,4-d)-pirimidina
ES549713A0 (es) Un procedimiento para preparar 1,4-dihidropiridinas
ES545347A0 (es) Un procedimiento para preparar derivados de pirimidina
ES548409A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES552032A0 (es) Un procedimiento para preparar derivados de 1,8-naftiridina
ES547419A0 (es) Un procedimiento para preparar derivados de pirimidina
ES543517A0 (es) Procedimiento para preparar un derivado de 1,3-oxazolidina-2-ona.
ES557659A0 (es) Un procedimiento para preparar derivados de ciclopentil-eter.
ES555010A0 (es) Un procedimiento para preparar derivados de 3-oxobutanamido-acetato.
ES552911A0 (es) Un procedimiento para preparar derivados de 3-carbonil-1-aminoalquil-1h-indol
ES545111A0 (es) Un procedimiento para preparar un derivado de fluoralilamina
ES546690A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indoldiona
ES547458A0 (es) Un procedimiento para preparar derivados de piridiloxi
ES557636A0 (es) Un procedimiento para preparar derivados de 3-amino-4-oxo-2,3,4,5-benzoxapina
ES541321A0 (es) Procedimiento para preparar un derivado de fenotiazina
ES550081A0 (es) Procedimiento para preparar un derivado de pirrolidina
ES545280A0 (es) Un procedimiento para preparar un derivado de 1,2,4,6-tia- triazina
ES551041A0 (es) Un procedimiento para preparar (1,2,4-oxadiazol-3-il)-arilmetanonas
ES534933A0 (es) Un procedimiento para preparar derivados de 1,6-naftiridina

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970203